MENU
Showcases Stock ranks Forex

Kenvue Inc (KVUE)
18.25  0.06 (0.33%) 03-05 16:00
Open: 18.06 Pre. Close: 18.19
High: 18.29 Low: 17.93
Volume: 41,812,534 Market Cap: 34,980(M)
Stock Technical Analysis
Overall:     
Target: Six months: 22.40
One year: 26.16
Support: Support1: 17.79
Support2: 16.94
Resistance: Resistance1: 19.17
Resistance2: 22.40
Pivot: 18.68
Moving Averages: MA(5): 18.52
MA(20): 18.53
MA(100): 16.83
MA(250): 19.21
MACD: MACD(12,26): 0.25
Signal(12,26,9): 0.37
%K %D: %K(14,3): 20.12
%D(3): 40.67
RSI: RSI(14): 49.98
52-Week: High: 25.17
Low: 14.02
Change(%): -17.9
Average Vol(K): 3-Month: 44503
10-Days: 31089
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 18.307 - 18.377 18.377 - 18.458
Low: 17.738 - 17.814 17.814 - 17.901
Close: 18.108 - 18.231 18.231 - 18.372
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.

[ KVUE ] has closed above bottom band by 14.1%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Stock chart
Stock News
Thu, 05 Mar 2026
Barclays raises Kenvue stock price target on category growth - Investing.com

Thu, 05 Mar 2026
Burgundy Asset Management Ltd. Trims Holdings in Kenvue Inc. $KVUE - MarketBeat

Wed, 04 Mar 2026
Kenvue (NYSE: KVUE) grants CTO 79,407 RSUs vesting 2027-2029 - Stock Titan

Wed, 04 Mar 2026
Kenvue (NYSE: KVUE) grants 63,525 RSUs to Chief Scientific Officer - Stock Titan

Tue, 03 Mar 2026
Kenvue Inc (KVUE) Trading Down 3.2% on Mar 3 - GuruFocus

Tue, 03 Mar 2026
Will Strong Q4 Results and Schafer Cullen’s Exit Change Kenvue’s (KVUE) Investment Narrative? - simplywall.st

Financial Analysis
Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Consumer Defensive
Industry:  Household & Personal Products
Shares Out. (M) 1920.00
Shares Float (M) 1910.00
% Held by Insiders 0.29
% Held by Institutions 96.20
Shares Short (K) 52530
Shares Short Prior Month (K) 81100
Stock Financials
EPS 0.760
Book Value (p.s.) 5.550
Profit Margin 9.72
Operating Margin 18.07
Return on Assets (ttm)
Return on Equity (ttm) 14.5
Qtrly Rev. Growth 3.2
Gross Profit (p.s.) 4.615
Sales Per Share 7.875
EBITDA (p.s.) 1.792
Qtrly Earnings Growth 11.20
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio 24.01
PEG Ratio
Price to Book value 3.29
Price to Sales 2.32
Price to Cash Flow
Stock Dividends
Dividend 0.210
Dividend Yield 0.01
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android